Cargando…

SUPPLEMENTING GLYNAC IN AGING IMPROVES GLUTATHIONE, MITOCHONDRIA, AND AGING HALLMARKS: A RANDOMIZED CLINICAL TRIAL

Oxidative stress (OxS), mitochondrial dysfunction and aging hallmarks are important contributors to aging, but effective solutions to correct these defects in older adults (OA) are lacking. Via earlier translational studies we discovered that supplementation of GlyNAC (combination of glycine and N-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekhar, Rajagopal, Kumar, Premranjan, Liu, Chun, Suliburk, James, Hsu, Jean, Jahoor, Farook, Minard, Charles, Taffet, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766452/
http://dx.doi.org/10.1093/geroni/igac059.389
_version_ 1784853733456216064
author Sekhar, Rajagopal
Kumar, Premranjan
Liu, Chun
Suliburk, James
Hsu, Jean
Jahoor, Farook
Minard, Charles
Taffet, George
author_facet Sekhar, Rajagopal
Kumar, Premranjan
Liu, Chun
Suliburk, James
Hsu, Jean
Jahoor, Farook
Minard, Charles
Taffet, George
author_sort Sekhar, Rajagopal
collection PubMed
description Oxidative stress (OxS), mitochondrial dysfunction and aging hallmarks are important contributors to aging, but effective solutions to correct these defects in older adults (OA) are lacking. Via earlier translational studies we discovered that supplementation of GlyNAC (combination of glycine and N-acetylcysteine) improves/corrects these defects. We conducted a double-blind, placebo-controlled (RCT) in 24 OA (mean age 71y) to definitively determine the effects of supplementing GlyNAC vs. isonitrogenous placebo (alanine) for 16-weeks on intracellular glutathione (GSH), OxS mitochondrial function, inflammation, insulin-resistance, endothelial function, physical function, body composition and multiple aging hallmarks. 12 YA (mean age 25y) served as young controls and received GlyNAC for 2-weeks. Subjects were studied before receiving supplementation study, and after receiving supplementation for 2-weeks (OA, YA) and 16-weeks (OA). The RCT found that compared to YA, the OA had severe GSH deficiency (red-cells, muscle), mitochondrial dysfunction, OxS (TBARS, F2-isoprostanes), diminished physical function (gait-speed, muscle strength, exercise capacity), elevated waist-circumference and systolic blood pressure, and multiple hallmarks defects of aging (affecting mitochondrial function, mitophagy, nutrient sensing, inflammation, insulin-resistance, genotoxicity, stem-cells and cellular senescence). GlyNAC supplementation for 2-weeks rapidly improved several defects, and further improved/corrected multiple defects after 16-weeks. No improvements were seen in YA receiving GlyNAC, or in OA receiving the alanine placebo, suggesting that protein supplementation per se in OA does not improve defects. The results of this RCT provides proof-of-concept that GlyNAC supplementation improves/reverses GSH deficiency, mitochondrial dysfunction, OxS, inflammation, physical function/strength and multiple aging hallmarks. GlyNAC could be a novel, simple and safe nutritional supplement to improve/reverse age-associated defects and promote health in aging humans.
format Online
Article
Text
id pubmed-9766452
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97664522022-12-20 SUPPLEMENTING GLYNAC IN AGING IMPROVES GLUTATHIONE, MITOCHONDRIA, AND AGING HALLMARKS: A RANDOMIZED CLINICAL TRIAL Sekhar, Rajagopal Kumar, Premranjan Liu, Chun Suliburk, James Hsu, Jean Jahoor, Farook Minard, Charles Taffet, George Innov Aging Abstracts Oxidative stress (OxS), mitochondrial dysfunction and aging hallmarks are important contributors to aging, but effective solutions to correct these defects in older adults (OA) are lacking. Via earlier translational studies we discovered that supplementation of GlyNAC (combination of glycine and N-acetylcysteine) improves/corrects these defects. We conducted a double-blind, placebo-controlled (RCT) in 24 OA (mean age 71y) to definitively determine the effects of supplementing GlyNAC vs. isonitrogenous placebo (alanine) for 16-weeks on intracellular glutathione (GSH), OxS mitochondrial function, inflammation, insulin-resistance, endothelial function, physical function, body composition and multiple aging hallmarks. 12 YA (mean age 25y) served as young controls and received GlyNAC for 2-weeks. Subjects were studied before receiving supplementation study, and after receiving supplementation for 2-weeks (OA, YA) and 16-weeks (OA). The RCT found that compared to YA, the OA had severe GSH deficiency (red-cells, muscle), mitochondrial dysfunction, OxS (TBARS, F2-isoprostanes), diminished physical function (gait-speed, muscle strength, exercise capacity), elevated waist-circumference and systolic blood pressure, and multiple hallmarks defects of aging (affecting mitochondrial function, mitophagy, nutrient sensing, inflammation, insulin-resistance, genotoxicity, stem-cells and cellular senescence). GlyNAC supplementation for 2-weeks rapidly improved several defects, and further improved/corrected multiple defects after 16-weeks. No improvements were seen in YA receiving GlyNAC, or in OA receiving the alanine placebo, suggesting that protein supplementation per se in OA does not improve defects. The results of this RCT provides proof-of-concept that GlyNAC supplementation improves/reverses GSH deficiency, mitochondrial dysfunction, OxS, inflammation, physical function/strength and multiple aging hallmarks. GlyNAC could be a novel, simple and safe nutritional supplement to improve/reverse age-associated defects and promote health in aging humans. Oxford University Press 2022-12-20 /pmc/articles/PMC9766452/ http://dx.doi.org/10.1093/geroni/igac059.389 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Sekhar, Rajagopal
Kumar, Premranjan
Liu, Chun
Suliburk, James
Hsu, Jean
Jahoor, Farook
Minard, Charles
Taffet, George
SUPPLEMENTING GLYNAC IN AGING IMPROVES GLUTATHIONE, MITOCHONDRIA, AND AGING HALLMARKS: A RANDOMIZED CLINICAL TRIAL
title SUPPLEMENTING GLYNAC IN AGING IMPROVES GLUTATHIONE, MITOCHONDRIA, AND AGING HALLMARKS: A RANDOMIZED CLINICAL TRIAL
title_full SUPPLEMENTING GLYNAC IN AGING IMPROVES GLUTATHIONE, MITOCHONDRIA, AND AGING HALLMARKS: A RANDOMIZED CLINICAL TRIAL
title_fullStr SUPPLEMENTING GLYNAC IN AGING IMPROVES GLUTATHIONE, MITOCHONDRIA, AND AGING HALLMARKS: A RANDOMIZED CLINICAL TRIAL
title_full_unstemmed SUPPLEMENTING GLYNAC IN AGING IMPROVES GLUTATHIONE, MITOCHONDRIA, AND AGING HALLMARKS: A RANDOMIZED CLINICAL TRIAL
title_short SUPPLEMENTING GLYNAC IN AGING IMPROVES GLUTATHIONE, MITOCHONDRIA, AND AGING HALLMARKS: A RANDOMIZED CLINICAL TRIAL
title_sort supplementing glynac in aging improves glutathione, mitochondria, and aging hallmarks: a randomized clinical trial
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766452/
http://dx.doi.org/10.1093/geroni/igac059.389
work_keys_str_mv AT sekharrajagopal supplementingglynacinagingimprovesglutathionemitochondriaandaginghallmarksarandomizedclinicaltrial
AT kumarpremranjan supplementingglynacinagingimprovesglutathionemitochondriaandaginghallmarksarandomizedclinicaltrial
AT liuchun supplementingglynacinagingimprovesglutathionemitochondriaandaginghallmarksarandomizedclinicaltrial
AT suliburkjames supplementingglynacinagingimprovesglutathionemitochondriaandaginghallmarksarandomizedclinicaltrial
AT hsujean supplementingglynacinagingimprovesglutathionemitochondriaandaginghallmarksarandomizedclinicaltrial
AT jahoorfarook supplementingglynacinagingimprovesglutathionemitochondriaandaginghallmarksarandomizedclinicaltrial
AT minardcharles supplementingglynacinagingimprovesglutathionemitochondriaandaginghallmarksarandomizedclinicaltrial
AT taffetgeorge supplementingglynacinagingimprovesglutathionemitochondriaandaginghallmarksarandomizedclinicaltrial